No definition available.
Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)
C3_BLADDER_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
5025 |
4. Check minimum number of eventsNone |
5025 |
5. Include endpointsNone |
5025 |
6. Filter based on genotype QC (FinnGen only) |
5025 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5025 | 891 | 4134 |
| Unadjusted period prevalence (%) | 1.55 | 0.30 | 1.82 |
| Median age at first event (years) | 70.87 | 68.00 | 71.49 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2682
- Matched controls
- 26795
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KCC10
NOMESCO Finland
Cystoprostatectomy
4614.2
323.0
406
*
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
140.0
323.0
502
44
C61
ICD-10 Finland
Malignant neoplasm of prostate
429.0
323.0
497
14
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
16384.0
323.0
1440
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
323.0
309
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
323.0
2064
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
323.0
782
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
226.2
323.0
980
68
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
806.7
323.0
671
11
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
323.0
480
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
1747.0
323.0
2008
45
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
323.0
1716
*
R31
ICD-10 Finland
Unspecified haematuria
12.2
323.0
1311
1941
UKC02
NOMESCO Finland
Cystoscopy
49.9
323.0
2332
3155
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
572
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
4778.6
323.0
418
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
74.6
323.0
385
60
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
3245.9
317.8
301
*
ZX136
NOMESCO Finland
Intravesicalis
225.7
313.5
319
16
H02AB02
ATC
dexamethasone; systemic
49.5
287.5
350
81
A03FA01
ATC
metoclopramide; systemic, rectal
7.0
232.5
642
1152
A04AA02
ATC
granisetron; systemic, transdermal
613.3
231.2
226
*
8130/3-C67.9
ICD-O-3
Papillary urothelial carcinoma of bladder, NOS
+∞
216.5
205
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
214.4
203
*
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
45.6
213.4
264
64
JN4BD
NOMESCO Finland
Extensive body CT
9.1
209.8
473
613
116
Kela drug reimbursment
Prostate cancer
+∞
209.0
198
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
204.7
194
*
J01MA02
ATC
ciprofloxacin; systemic
3.5
198.5
1518
7318
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
76.0
197.4
224
32
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
377.1
178.6
178
5
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
20.0
178.3
275
152
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
174.8
166
*
JN4AD
NOMESCO Finland
Body CT examination
10.5
174.3
359
389
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.6
168.1
473
840
J01EA01
ATC
trimethoprim; systemic
3.7
163.5
891
3158
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
+∞
163.1
155
*
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
+∞
161.0
153
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.7
159.8
875
3103
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
18.8
149.4
235
136
KCB00
NOMESCO Finland
Biopsy of bladder
83.7
147.1
165
21
WF049
NOMESCO Finland
Radiotherapy of metastasis
1504.1
146.1
141
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
146.1
139
*
U76
ICPC
Malignant neoplasm of bladder
+∞
144.0
137
*
7323
FHL
Electrosection of TU bladder wall change
370.9
142.2
142
*
Z51.5
ICD-10 Finland
Palliative care
10.1
140.9
294
322
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
139.7
133
*
XKD00
NOMESCO Finland
Uroflowmetry
3.3
136.8
890
3527
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
134.4
128
*
A04AD12
ATC
aprepitant; systemic
+∞
134.4
128
*
JN4CD
NOMESCO Finland
Very extensive body CT
15.8
129.4
217
148
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.6
128.8
704
2425
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
111.7
127.2
138
13
L02AE02
ATC
leuprorelin; implant, parenteral
196.3
126.7
131
7
KCW96
NOMESCO Finland
Other operations on bladder
55.0
126.6
151
29
WF002
NOMESCO Finland
Radical radiotherapy
127.0
124.2
133
11
TJF80
NOMESCO Finland
Ostomy education
95.4
123.3
136
15
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
28.5
122.8
169
63
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
76.8
122.6
139
19
KA1AE
NOMESCO Finland
Kidney ultrasound examination
13.0
121.7
222
184
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
+∞
121.7
116
*
TKC20
NOMESCO Finland
Catheterisation of bladder
4.4
120.5
496
1323
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
186.9
120.5
125
7
A04AA01
ATC
ondansetron; systemic, rectal
18.1
116.9
186
110
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
112.2
107
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
111.0
736
2883
U06
ICPC
Haematuria
10.4
111.0
227
237
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.4
109.8
278
414
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.4
109.5
617
2139
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
32.0
109.5
146
48
WX320
NOMESCO Finland
Spinalanesthesy
2.9
107.9
827
3560
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
+∞
106.9
102
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
12.5
106.1
197
169
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
105.9
101
*
B01AB10
ATC
tinzaparin; parenteral
7.1
105.3
273
420
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.2
104.2
668
2537
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
126.0
101.7
109
9
WX302
NOMESCO Finland
Thoracal epidural anesthesy
11.2
101.2
198
189
KC1GB
NOMESCO Finland
Cystography with X-ray
113.4
100.7
109
10
8120/3-C67.2
ICD-O-3
Transitional cell carcinoma, NOS, of lateral wall of bladder
+∞
100.6
96
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
97.4
93
*
L02BB03
ATC
bicalutamide; oral
971.0
96.5
94
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.3
94.9
268
462
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
478.4
93.9
93
*
7321
FHL
TU biopsy, coagulation or laser
51.1
93.7
113
23
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
93.2
89
*
N02AA05
ATC
oxycodone; systemic
3.3
90.9
532
1872
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
906.8
90.2
88
*
B02AA02
ATC
tranexamic acid; systemic
4.3
90.1
366
946
ZXC20
NOMESCO Finland
Use of chemical agents
15.4
85.6
144
98
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
84.8
81
*
KA3EB
NOMESCO Finland
Antegrade pyelography
62.7
83.2
97
16
J01MA12
ATC
levofloxacin; systemic
2.7
81.2
700
3141
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
60.7
80.3
94
16
A04AA55
ATC
palonosetron, combinations; systemic
+∞
79.5
76
*
WZC30
NOMESCO Finland
Teaching
3.9
78.6
352
989
B01AB05
ATC
enoxaparin; parenteral
2.4
75.8
837
4273
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
72.2
69
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
71.1
68
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
68.7
472
1822
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
684.2
68.3
67
*
KCD30
NOMESCO Finland
Destruction of tumour of bladder
124.8
68.2
73
6
KA1FN
NOMESCO Finland
Isotope renography
35.9
67.3
87
25
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
65.9
63
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
65.7
429
1597
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.5
64.6
177
290
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
324.1
63.7
64
*
KDV10
NOMESCO Finland
Internal urethrotomy
7.9
63.1
149
197
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
621.2
62.0
61
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
61.7
59
*
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
+∞
61.7
59
*
JEA00
NOMESCO Finland
Appendectomy
4.8
61.6
218
484
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.4
61.3
195
385
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
610.8
61.0
60
*
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
+∞
60.6
58
*
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
59.6
57
*
1530
FHL
Urethrocystoscopy
5.6
59.5
181
339
L03AA02
ATC
filgrastim; parenteral
84.5
59.1
66
8
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
59.1
1220
7965
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
58.6
329
1097
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
75.2
58.3
66
9
UKB02
NOMESCO Finland
Retrograde ureteroscopy
11.9
58.1
109
95
ZX090
NOMESCO Finland
Other technic of radiotherapy
126.7
58.0
62
5
JN3AD
NOMESCO Finland
Abdominal CT examination
3.7
57.7
274
801
Y77
ICPC
Malignant neoplasm prostate
153.1
57.1
60
*
WX402
NOMESCO Finland
General anaesthesia
3.1
56.7
339
1179
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
56.4
54
*
N30.0
ICD-10 Finland
Acute cystitis
2.9
56.4
382
1448
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
197.2
56.2
58
*
1889X
ICD-9 Finland
Malignant neoplasm of bladder, Bladder, part unspecified
+∞
54.3
52
*
L03AA13
ATC
pegfilgrastim; parenteral
537.7
53.7
53
*
KH1AD
NOMESCO Finland
CT of urinary organs
5.6
53.4
164
310
R33
ICD-10 Finland
Retention of urine
2.5
52.9
468
2071
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
52.2
360
1376
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
10.5
51.8
103
101
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.3
51.3
103
103
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.9
51.2
150
268
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
95.2
51.0
56
6
8000/3-C67.9
ICD-O-3
Neoplasm, malignant of bladder, NOS
+∞
50.1
48
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.8
49.5
172
374
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
169.5
48.0
50
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
169.5
48.0
50
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
47.6
418
1835
J01CA08
ATC
pivmecillinam; oral
2.2
46.6
595
3129
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
86.6
45.9
51
6
XKD10
NOMESCO Finland
Transurethral ultrasonography
+∞
45.9
44
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
124.5
45.9
49
*
PJA12
NOMESCO Finland
Sentinel node biopsy
454.6
45.4
45
*
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
46.7
45.2
55
12
N02BE01
ATC
paracetamol; systemic, rectal
1.9
44.9
2041
16786
WX224
NOMESCO Finland
Blockade of obturius nerve
444.2
44.3
44
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.3
44.0
121
199
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
228.4
44.0
45
*
18899
ICD-8 Finland
Malignant neoplasm of bladder
+∞
42.8
41
*
SPAT1125
SPAT
Stoma care and guidance
7.3
42.8
106
151
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
9.4
42.6
90
99
4CX01
NOMESCO Finland
NA
423.5
42.2
42
*
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
41.7
40
*
J01DB01
ATC
cefalexin; oral
1.8
41.7
1858
14941
ZX070
NOMESCO Finland
Intensity modified radiotherapy
413.1
41.2
41
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
11.1
40.6
78
72
NK6AN
NOMESCO Finland
Total body bone isotope imaging
40.7
38.5
48
12
KWA00
NOMESCO Finland
Repair of wound dehiscence in urological surgery
+∞
37.6
36
*
KCC00
NOMESCO Finland
Cystectomy
371.8
37.1
37
*
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
+∞
36.5
35
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
17.6
36.3
57
33
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
35.9
555
3118
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
35.5
34
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
79.1
34.9
39
5
WW500
NOMESCO Finland
Blood transfusion
5.1
34.4
113
231
115
Kela drug reimbursment
Breast cancer
+∞
34.4
33
*
L01BC06
ATC
capecitabine; oral
+∞
34.4
33
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.2
34.1
136
339
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
177.0
33.8
35
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
25.1
33.6
47
19
KED22
NOMESCO Finland
Transurethral resection of prostate
2.3
33.3
355
1699
A79
ICPC
Malignancy NOS
64.1
33.0
38
6
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
6.6
32.9
86
133
N30.9
ICD-10 Finland
Cystitis, unspecified
3.2
32.9
185
610
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
32.3
31
*
SPAT1262
SPAT
Handing over of treatment supplies
1.9
32.3
545
3148
WX882
NOMESCO Finland
High dependency care
4.2
32.0
126
311
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
320.3
31.9
32
*
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
24.8
31.4
44
18
U99
ICPC
Urinary disease other
9.0
31.3
67
76
KBJ80
NOMESCO Finland
Operation for malfunction of urinary diversion
+∞
31.3
30
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.3
31.1
299
1358
G04CA02
ATC
tamsulosin; oral
1.6
30.3
1100
8011
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
30.2
29
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
30.2
29
*
UKD02
NOMESCO Finland
Urethroscopy
13.6
30.0
52
39
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.2
29.5
161
521
8120/3-C67.4
ICD-O-3
Transitional cell carcinoma, NOS, of posterior wall of bladder
+∞
29.2
28
*
UKC12
NOMESCO Finland
Retrograde endoscopy of cutaneous cystoenterostomy
+∞
29.2
28
*
8120/3-C67.8
ICD-O-3
Transitional cell carcinoma, NOS, of overlapping lesion of bladder
+∞
29.2
28
*
G04BE03
ATC
sildenafil; oral
15.4
28.6
47
31
U28
ICPC
Limited function/disability (U)
6.6
28.3
74
115
A06AH03
ATC
naloxegol; oral
18.9
28.3
43
23
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
28.2
27
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
28.2
27
*
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
6.7
28.0
72
109
Z51.0
ICD-10 Finland
Radiotherapy session
283.9
27.8
28
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
283.9
27.8
28
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
283.9
27.8
28
*
J01MA01
ATC
ofloxacin; systemic
2.2
27.1
308
1507
C67.7
ICD-10 Finland
Malignant neoplasm: Urachus
+∞
27.1
26
*
U77
ICPC
Malignant neopl urinary tract other
+∞
27.1
26
*
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
26.7
27.1
37
14
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
62.6
27.0
31
5
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
22.6
26.5
38
17
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
26.1
25
*
G04BD08
ATC
solifenacin; oral
2.5
25.8
214
897
U07
ICPC
Urine symptom/complaint other
2.7
25.7
179
679
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
136.1
25.6
27
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
25.0
24
*
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
+∞
25.0
24
*
UKB12
NOMESCO Finland
Retrograde endoscopy of cutaneous ureteroenterostomy
+∞
25.0
24
*
R50.9
ICD-10 Finland
Fever, unspecified
2.0
24.9
342
1814
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
26.4
24.8
34
13
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
43.2
24.6
30
7
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
24.0
23
*
L02AE03
ATC
goserelin; implant
67.9
23.8
27
*
N02AX02
ATC
tramadol; systemic, rectal
1.5
23.7
1004
7461
R4110
NOMESCO Finland
Physiotherapy
1.7
23.6
562
3590
ZXC96
NOMESCO Finland
Robot assisted procedure
16.3
23.2
37
23
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
22.9
22
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
22.9
22
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.2
22.8
121
384
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
84.0
22.7
25
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
231.5
22.6
23
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
231.5
22.6
23
*
J01MA06
ATC
norfloxacin; oral
2.0
22.6
309
1629
ZZR00
NOMESCO Finland
Flap of skin
9.1
22.0
46
51
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
21.9
21
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
21.9
21
*
3AX03
NOMESCO Finland
NA
+∞
21.9
21
*
Z93.6
ICD-10 Finland
Other artificial openings of urinary tract status
80.7
21.7
24
*
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
3.9
21.6
91
240
U29
ICPC
Urinary symptom/complaint other
3.6
21.6
99
281
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
21.1
167
684
Z93
ICD-10 Finland
Artificial opening status
28.2
20.9
28
10
8120/3-C67.6
ICD-O-3
Transitional cell carcinoma, NOS, of ureteric orifice
+∞
20.8
20
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
20.8
20
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
20.8
20
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
20.8
20
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
20.8
20
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
20.8
20
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
77.3
20.7
23
*
KBD00
NOMESCO Finland
Partial excision of ureter
211.2
20.6
21
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.9
20.4
128
456
KBH20
NOMESCO Finland
Replantation of ureter
48.3
20.1
24
5
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
13.1
20.1
35
27
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
19.9
613
4176
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
19.8
235
1170
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
19.8
19
*
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
+∞
19.8
19
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
19.8
19
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
19.8
19
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
19.8
19
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
19.8
19
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
19.8
19
*
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
13.2
19.7
34
26
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
19.3
921
6943
GD1AD
NOMESCO Finland
Thorax CT examination
2.9
19.3
118
415
ZX120
NOMESCO Finland
Intravenous
2.2
19.1
202
953
G04BD12
ATC
mirabegron; oral
2.0
19.1
267
1419
J01CA04
ATC
amoxicillin; systemic
1.5
18.9
1657
14107
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
18.8
18
*
8120/3-C67.1
ICD-O-3
Transitional cell carcinoma, NOS, of dome of bladder
+∞
18.8
18
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
18.8
18
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
18.8
18
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
18.8
18
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
18.8
18
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
18.8
18
*
8120/3-C67.5
ICD-O-3
Transitional cell carcinoma, NOS, of bladder neck
+∞
18.8
18
*
WC135
NOMESCO Finland
Very demanding cytostatic therapy of local tumor recidive
+∞
18.8
18
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
18.8
18
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
18.8
18
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
70.3
18.7
21
*
SPAT1167
SPAT
Insertion of urinary catheter
2.5
18.7
146
595
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
191.0
18.5
19
*
U05
ICPC
Urination problems other
2.4
18.4
158
674
KA3GB
NOMESCO Finland
Retrograde pyelography
25.2
18.2
25
10
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
10.4
18.1
35
34
JAH00
NOMESCO Finland
Laparotomy
3.4
17.9
87
260
KH1CB
NOMESCO Finland
Urography with X-ray
18.1
17.8
27
15
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
17.7
17
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
17.7
17
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
17.7
17
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
17.7
17
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
17.7
17
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
17.7
17
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
17.7
17
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.4
17.6
85
253
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
180.9
17.5
18
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
180.9
17.5
18
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
180.9
17.5
18
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.7
17.3
118
441
KAC10
NOMESCO Finland
Total nephrectomy with capsule
42.2
17.3
21
5
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
17.1
186
890
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.9
17.1
106
377
WX110
NOMESCO Finland
Local anesthesy
1.4
17.0
1200
9709
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
10.8
16.9
32
30
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.5
16.8
59
132
KBV10
NOMESCO Finland
Removal of stent from ureter
8.1
16.7
37
46
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
16.7
16
*
7343
FHL
Cystectomy and enterocystoplasty
+∞
16.7
16
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
16.7
16
*
KWW96
NOMESCO Finland
Other reoperation in urological surgery
90.5
16.6
18
*
A02BC02
ATC
pantoprazole; systemic
1.4
16.5
1387
11567
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
170.8
16.5
17
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.8
15.9
67
179
U13
ICPC
Bladder symptom/complaint other
3.2
15.9
83
263
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
15.7
653
4736
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
15.6
72
207
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
15.6
15
*
1850A
ICD-9 Finland
Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]
+∞
15.6
15
*
L02BG04
ATC
letrozole; oral
85.5
15.6
17
*
XJH00
NOMESCO Finland
Transanal ultrasonography
1.9
15.5
225
1209
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.8
15.5
66
178
UKC22
NOMESCO Finland
Urethroneocystoscopy
160.7
15.5
16
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
160.7
15.5
16
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
160.7
15.5
16
*
JFB30
NOMESCO Finland
Right hemicolectomy
8.2
15.5
34
42
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.1
15.5
174
845
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
9.5
15.4
31
33
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.5
15.4
45
83
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
5.4
15.2
45
84
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.9
15.2
62
161
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
15.0
251
1419
D70.82
ICD-10 Finland
Drug-induced neutropenia
10.9
15.0
28
26
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
56.9
14.8
17
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.8
14.7
61
161
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
14.6
14
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
14.6
14
*
KH1RT
NOMESCO Finland
Urinary tract dilatatation with radiological guidance
+∞
14.6
14
*
L02BX02
ATC
degarelix; parenteral
+∞
14.6
14
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
14.6
14
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
14.6
14
*
KCJ10
NOMESCO Finland
Cutaneous cystoenterostomy
+∞
14.6
14
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
14.6
14
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
14.6
14
*
KDC00
NOMESCO Finland
Urethrectomy
+∞
14.6
14
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
14.6
14
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
14.6
14
*
N13.0
ICD-10 Finland
Hydronephrosis with ureteropelvic junction obstruction
7.7
14.6
33
43
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
150.6
14.5
15
*
7339
FHL
Other measure in this category
150.6
14.5
15
*
U79
ICPC
Neoplasm urinary tract unspecified
150.6
14.5
15
*
G04BE01
ATC
alprostadil; parenteral, urethral
2.8
14.3
92
333
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
22.3
14.2
20
9
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
14.2
167
826
U14
ICPC
Kidney symptom/complaint
3.8
14.1
59
157
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
14.1
100
387
KCD10
NOMESCO Finland
Partial cystectomy
42.6
14.1
17
*
KH1DD
NOMESCO Finland
CT urography of urinary organs
42.6
14.1
17
*
A41.8
ICD-10 Finland
Other specified sepsis
3.5
14.0
66
194
UJF32
NOMESCO Finland
Coloscopy
1.5
13.9
538
3824
7326
FHL
Bladder lavage
15.8
13.9
22
14
JFF23
NOMESCO Finland
Transversostomy
12.7
13.9
24
19
S77
ICPC
Malignant neoplasm of skin
17.6
13.8
21
12
4078
NOMESCO Finland
NA
53.5
13.8
16
*
2394A
ICD-9 Finland
Neoplasm of unspecified nature, Bladder
53.5
13.8
16
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.2
13.7
144
681
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
13.5
13
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
13.5
13
*
1880A
ICD-9 Finland
Malignant neoplasm of bladder, Trigone of urinary bladder
+∞
13.5
13
*
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
13.5
13
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
13.5
13
*
L02BX03
ATC
abiraterone; oral
+∞
13.5
13
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
13.5
13
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
13.5
13
*
U70
ICPC
Pyelonephritis/pyelitis
4.6
13.5
46
101
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
140.5
13.4
14
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
140.5
13.4
14
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
140.5
13.4
14
*
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
5.6
13.4
38
68
L02BA01
ATC
tamoxifen; oral
40.2
13.1
16
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.9
13.1
42
87
N21.0
ICD-10 Finland
Calculus in bladder
3.8
13.1
54
143
TQW99
NOMESCO Finland
Other minor procedure on skin
2.7
12.9
88
332
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.3
12.9
64
197
WX002
NOMESCO Finland
Sedation and analgesia
1.6
12.9
409
2777
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
12.8
188
1014
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
12.6
241
1423
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
70.1
12.6
14
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
12.5
12
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
12.5
12
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
12.5
12
*
L02BB04
ATC
enzalutamide; oral
+∞
12.5
12
*
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
+∞
12.5
12
*
N99.5
ICD-10 Finland
Malfunction of external stoma of urinary tract
17.4
12.5
19
11
G03HA01
ATC
cyproterone; systemic
24.4
12.4
17
7
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
130.4
12.4
13
*
ZX112
NOMESCO Finland
Subcutaneous
6.3
12.4
32
51
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
12.3
445
3107
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
4.0
12.1
47
118
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.9
12.1
190
1052
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
12.0
124
580
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
4.1
12.0
46
114
KCH10
NOMESCO Finland
Enterocystoplasty
46.8
11.9
14
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
11.7
577
4299
A41.9
ICD-10 Finland
Sepsis, unspecified
2.2
11.6
122
578
TKC00
NOMESCO Finland
Needle biopsy of bladder
65.1
11.6
13
*
U71
ICPC
Cystitis/urinary infection other
2.5
11.6
92
382
U02
ICPC
Urinary frequency/urgency
1.8
11.5
214
1256
C50.99
ICD-10 Finland
Breast, unspecified
+∞
11.5
11
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
11.5
11
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
11.5
11
*
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
+∞
11.5
11
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
11.5
11
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
11.5
11
*
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
+∞
11.5
11
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
11.5
11
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
11.5
11
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
11.5
11
*
L01CA04
ATC
vinorelbine; systemic
+∞
11.5
11
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
11.5
11
*
8140/3-C67.9
ICD-O-3
Adenocarcinoma, NOS, of bladder, NOS
+∞
11.5
11
*
U04
ICPC
Incontinence urine
2.2
11.4
113
522
A28
ICPC
Limited function/disability NOS
1.5
11.4
458
3270
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.9
11.4
67
233
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
17.1
11.2
17
10
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
3.3
11.0
53
161
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.2
10.8
104
474
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
28.1
10.7
14
5
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.5
10.7
443
3180
HAC20
NOMESCO Finland
Total mastectomy
60.1
10.6
12
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
60.1
10.6
12
*
JAG41
NOMESCO Finland
Repair of stomal hernia, laparoscopic
60.1
10.6
12
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
11.2
10.5
19
17
JN6AD
NOMESCO Finland
CT of torso and neck
10.0
10.5
20
20
WX704
NOMESCO Finland
Intubation
2.0
10.5
135
696
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
110.3
10.4
11
*
KBB00
NOMESCO Finland
Biopsy of ureter
110.3
10.4
11
*
KDW98
NOMESCO Finland
Other transluminal endoscopic operations on urethra
110.3
10.4
11
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
110.3
10.4
11
*
JAG43
NOMESCO Finland
Repair of stomal hernia with mesh
110.3
10.4
11
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
10.4
10
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
10.4
10
*
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
+∞
10.4
10
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
10.4
10
*
8041/3-C67.9
ICD-O-3
Small cell carcinoma, NOS, of bladder, NOS
+∞
10.4
10
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
10.4
10
*
SPAT1168
SPAT
Catheterisation training
4.7
10.4
34
73
WX400
NOMESCO Finland
Inhalation anesthesy
2.7
10.3
69
259
S18
ICPC
Laceration/cut
1.3
10.3
825
6654
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.6
10.3
76
302
B01AB04
ATC
dalteparin; parenteral
2.2
10.3
107
505
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
6.0
10.3
27
45
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
9.6
10.2
20
21
TKC22
NOMESCO Finland
Catheterisation instruction
2.7
10.2
68
255
G04AC01
ATC
NA
2.8
10.1
63
227
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.6
10.0
44
125
D75
ICPC
Malignant neoplasm colon/rectum
40.1
10.0
12
*
KGH10
NOMESCO Finland
Operation for phimosis
2.4
9.8
81
344
GDC00
NOMESCO Finland
Lobectomy of lung
26.1
9.8
13
5
1544
FHL
Urinary tract endoscopy
20.1
9.8
14
7
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
10.6
9.8
18
17
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
9.7
249
1600
M05BX04
ATC
denosumab; parenteral
2.6
9.7
69
269
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
5.0
9.7
30
61
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.4
9.6
79
335
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
9.6
342
2380
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.9
9.5
140
760
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
9.5
340
2365
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
9.5
348
2433
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
3.3
9.5
45
136
G04CA01
ATC
alfuzosin; oral
1.4
9.4
436
3196
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
100.2
9.4
10
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
100.2
9.4
10
*
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
3.5
9.4
42
121
J01XE01
ATC
nitrofurantoin; oral
3.5
9.4
42
121
Z93.5
ICD-10 Finland
Cystostomy status
6.6
9.4
23
35
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
30.1
9.4
12
*
KCV02
NOMESCO Finland
Cystoscopic balloon distension of bladder
17.6
9.4
14
8
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
17.6
9.4
14
8
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
9.4
9
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
9.4
9
*
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
+∞
9.4
9
*
8120/3-C67.0
ICD-O-3
Transitional cell carcinoma, NOS, of trigone of bladder
+∞
9.4
9
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.4
9
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
9.4
9
*
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
+∞
9.4
9
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
9.4
9
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
9.4
9
*
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
9.4
9
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
9.4
9
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
9.4
9
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
9.4
9
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
9.4
9
*
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
+∞
9.4
9
*
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
+∞
9.4
9
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
9.4
9
*
L01CB01
ATC
etoposide; systemic
+∞
9.4
9
*
8120/3-C65.9
ICD-O-3
Transitional cell carcinoma, NOS, of renal pelvis
+∞
9.4
9
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
9.4
9
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
9.4
9
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
9.4
9
*
Z43.6
ICD-10 Finland
Attention to other artificial openings of urinary tract
21.7
9.3
13
6
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
9.3
221
1391
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.5
9.2
31
69
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
3.4
9.2
43
129
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.9
9.1
125
664
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
9.0
155
888
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
15.6
9.0
14
9
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
9.0
134
731
N07BA03
ATC
varenicline; oral
2.6
9.0
65
257
N30
ICD-10 Finland
Cystitis
2.1
9.0
96
461
A06AD11
ATC
lactulose; oral
1.4
9.0
440
3259
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
9.0
898
7455
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.6
8.9
260
1724
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
18.6
8.9
13
7
N02
ICD-10 Finland
Recurrent and persistent haematuria
9.5
8.8
17
18
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
5.9
8.7
23
39
L02BG03
ATC
anastrozole; oral
50.1
8.7
10
*
RD211
NOMESCO Finland
NA
2.2
8.6
83
379
Z93.3
ICD-10 Finland
Colostomy status
10.0
8.5
16
16
L57.0
ICD-10 Finland
Actinic keratosis
1.7
8.5
171
1030
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
27.6
8.5
11
*
N05CF01
ATC
zopiclone; oral
1.3
8.4
765
6254
KH1EE
NOMESCO Finland
Urologic ultrasound examination
7.9
8.3
18
23
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
3.5
8.3
37
107
G04BE30
ATC
drugs used in erectile dysfunction - combinations
+∞
8.3
8
*
L02AE04
ATC
triptorelin; parenteral
+∞
8.3
8
*
198
Kela drug reimbursment
Sorafenib
+∞
8.3
8
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
8.3
8
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
8.3
8
*
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
+∞
8.3
8
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
8.3
8
*
C18.2
ICD-10 Finland
Malignant neoplasm: Ascending colon
+∞
8.3
8
*
KBJ00
NOMESCO Finland
Cutaneous ureterostomy
+∞
8.3
8
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
+∞
8.3
8
*
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
+∞
8.3
8
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
8.3
8
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
8.3
8
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
8.3
8
*
7342
FHL
Cystectomy and differential surgery
+∞
8.3
8
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
8.3
8
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
8.3
8
*
N30.4
ICD-10 Finland
Irradiation cystitis
+∞
8.3
8
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.4
8.2
38
114
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
33.4
8.1
10
*
A03
ICPC
Fever
1.6
8.1
199
1267
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
17.2
8.1
12
7
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.3
8.0
28
66
HA1AA
NOMESCO Finland
X-ray mammography
3.5
7.9
35
101
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
3.4
7.9
36
107
J01DA01
ATC
[U] cefalexin; systemic
1.3
7.9
1354
11980
U01
ICPC
Dysuria/painful urination
2.0
7.8
90
449
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
9.4
7.8
15
16
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
7.7
150
893
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
4.0
7.7
29
73
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
7.7
1719
15668
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.1
7.7
39
125
U75
ICPC
Malignant neoplasm of kidney
45.0
7.7
9
*
A18.1
ICD-10 Finland
Tuberculosis of genitourinary system
45.0
7.7
9
*
KAD00
NOMESCO Finland
Partial nephrectomy
15.0
7.7
12
8
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.8
7.7
130
742
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
7.6
285
1998
JF1AD
NOMESCO Finland
Small bowel CT
6.7
7.6
18
27
N35.9
ICD-10 Finland
Urethral stricture, unspecified
2.8
7.6
46
167
KD1GB
NOMESCO Finland
Uretrocystogpaphy with X-ray
11.8
7.6
13
11
N30.8
ICD-10 Finland
Other cystitis
6.2
7.5
19
31
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.2
7.4
68
307
TQW40
NOMESCO Finland
Remowal of suture of skin
1.9
7.4
100
530
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
4.8
7.4
23
48
M05BA02
ATC
clodronic acid; systemic
80.2
7.4
8
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
80.2
7.4
8
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
13.4
7.4
12
9
KDE20
NOMESCO Finland
Removal of foreign body from urethra
5.3
7.4
21
40
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.1
7.3
37
119
SPAT1254
SPAT
Administration of medicine
1.4
7.3
337
2464
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.8
7.3
118
664
WX892
NOMESCO Finland
Monitored bed care
1.6
7.3
171
1075
8070/3-C67.9
ICD-O-3
Squamous cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
7.3
7
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
7.3
7
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
7.3
7
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
7.3
7
*
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
+∞
7.3
7
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
7.3
7
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
7.3
7
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
7.3
7
*
8130/3-C67.2
ICD-O-3
Papillary urothelial carcinoma of lateral wall of bladder
+∞
7.3
7
*
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
+∞
7.3
7
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
7.3
7
*
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
+∞
7.3
7
*
8010/3-C67.9
ICD-O-3
Carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
7.3
7
*
Z72.0
ICD-10 Finland
Tobacco use
2.8
7.3
43
153
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
5.8
7.2
19
33
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.4
7.2
32
94
R03BB04
ATC
tiotropium bromide; inhalant
1.4
7.2
332
2431
DAB10
NOMESCO Finland
Partial excision of auricle
30.0
7.1
9
*
5997A
ICD-9 Finland
Other disorders of urethra and urinary tract, Haematuria
3.8
7.1
28
74
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.9
7.1
41
142
P01AB01
ATC
metronidazole; oral, rectal
1.3
7.1
625
5066
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
6.6
7.1
17
26
U08
ICPC
Urinary retention
2.2
7.1
65
294
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
8.8
7.0
14
16
R4190
NOMESCO Finland
Nutritional therapy
3.3
7.0
33
101
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
7.0
130
767
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
4.3
7.0
24
56
JFB00
NOMESCO Finland
Partial resection of small intestine
3.0
7.0
37
124
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
3.3
6.9
32
97
V03AE01
ATC
polystyrene sulfonate; oral
2.6
6.9
48
187
1549
FHL
Other endoscopy
13.8
6.9
11
8
H02AB06
ATC
prednisolone; systemic
1.3
6.9
999
8619
C03CA01
ATC
furosemide; systemic
1.2
6.9
1017
8794
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.2
6.9
64
293
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.9
6.8
26
67
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
2.6
6.8
45
172
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.1
6.8
35
115
KC1GD
NOMESCO Finland
CT cystography of bladder
40.1
6.8
8
*
KBH96
NOMESCO Finland
Other repair or connection of ureter
40.1
6.8
8
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
40.1
6.8
8
*
KEB00
NOMESCO Finland
Biopsy of prostate
3.6
6.7
28
78
Z43.5
ICD-10 Finland
Attention to cystostomy
3.4
6.7
30
89
N18.8
ICD-10 Finland
Other chronic renal failure
1.9
6.7
92
493
R50.8
ICD-10 Finland
Other specified fever
7.2
6.7
15
21
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
2.0
6.7
85
441
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
7.8
6.6
14
18
G04BD07
ATC
tolterodine; oral
1.7
6.6
122
720
WX702
NOMESCO Finland
Supraglottic ventilation device
2.0
6.6
82
422
KK1XE
NOMESCO Finland
Other ultrasound examination of retroperitoneal space and genito-urinary tract
10.0
6.5
12
12
KC1AE
NOMESCO Finland
Percutaneous ultrasound examination of urinary bladder
6.8
6.5
15
22
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
4.0
6.5
24
61
SPAT1255
SPAT
Intravenous administration of medicine
1.7
6.4
141
871
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
69.9
6.4
7
*
22330
ICD-8 Finland
Benign neoplasm of kidney and other urinary organs, Bladder
69.9
6.4
7
*
2233A
ICD-9 Finland
Benign neoplasm of kidney and other urinary organs, Bladder
69.9
6.4
7
*
K43.5
ICD-10 Finland
Parastomal hernia without obstruction or gangrene
69.9
6.4
7
*
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
69.9
6.4
7
*
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.6
6.4
177
1164
R18
ICD-10 Finland
Ascites
2.9
6.4
37
130
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
4.7
6.4
20
43
N02AA01
ATC
morphine; systemic, rectal
3.4
6.4
28
82
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.8
6.4
101
569
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
11.0
6.3
11
10
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
18.0
6.3
9
5
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
6.3
781
6603
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
6.2
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.2
6
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
6.2
6
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
6.2
6
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
6.2
6
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
6.2
6
*
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
+∞
6.2
6
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
6.2
6
*
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
+∞
6.2
6
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
+∞
6.2
6
*
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
+∞
6.2
6
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
6.2
6
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
6.2
6
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
6.2
6
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.2
6
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
6.2
6
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
6.2
6
*
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
+∞
6.2
6
*
KAD52
NOMESCO Finland
Retrograde ureteronephroscopic destruction of tumour of pelvis of kidney
+∞
6.2
6
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.2
6
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
6.2
6
*
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
6.2
6
*
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
6.2
6
*
8120/3-C66.9
ICD-O-3
Transitional cell carcinoma, NOS, of ureter
+∞
6.2
6
*
KDD30
NOMESCO Finland
Destruction of tumour of urethra
+∞
6.2
6
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
6.2
6
*
KBC00
NOMESCO Finland
Ureterectomy
+∞
6.2
6
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
6.2
6
*
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
+∞
6.2
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.2
6
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
6.2
6
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
6.2
6
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
26.7
6.2
8
*
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
3.0
6.2
32
106
R39.1
ICD-10 Finland
Other difficulties with micturition
1.9
6.1
81
428
E87.5
ICD-10 Finland
Hyperkalaemia
2.2
6.1
58
267
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
6.1
435
3414
D40.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Male genital organ, unspecified
12.5
6.1
10
8
JDE00
NOMESCO Finland
Gastrojejunostomy
12.5
6.1
10
8
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
6.1
465
3689
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.0
6.1
76
392
TKC50
NOMESCO Finland
Training of urinary bladder
8.6
6.0
12
14
ZQZ00
NOMESCO Finland
Treatment of several skin areas
8.6
6.0
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3031040) Bacteria [#/volume] in Urine by Automated count
3774
23525
3.41
316.28
12.6
4.3
e6/l
845.3
1373.1
0.33
71
485
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2848
15300
2.98
308.61
5.7
3.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2572
9747
4.34
307.65
3.1
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
2526
11733
3.31
307.65
9.7
3.1
e6/l
371.0
116.5
3.05
2208
9128
(4035726)
743
961
8.88
307.65
1.4
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
2631
13243
3.06
307.65
10.5
3.5
e6/l
249.3
121.3
2.92
2289
9717
(3026008) Bacteria identified in Urine by Culture
2826
10523
4.84
307.65
6.0
3.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
2291
10594
3.13
307.65
9.4
3.0
e6/l
0.3
0.5
4.45
1957
8040
(3002256) Pathology report gross observation
1675
2489
9.57
307.65
1.8
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
2005
8165
3.41
307.65
5.8
2.5
e6/l
4.2
3.7
1.12
1851
7084
(3049717) Cytology report of Urine Cyto stain
2728
1615
35.68
307.65
6.0
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
2149
10013
2.99
301.00
9.4
3.0
—
—
—
0
0
(3026782) Osmolality of Urine
1762
7572
3.03
282.27
6.3
2.7
mosm/kgh2o
566.0
570.5
0.43
1594
6351
(3044640) Blood type and Crossmatch panel - Blood
2130
10354
2.83
268.78
3.3
2.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1475
6094
3.00
248.93
9.4
2.8
e6/l
1.1
1.5
2.42
1113
3484
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1532
6540
2.92
242.71
8.6
2.7
e6/l
1.7
1.1
4.18
1163
3901
(3037467) Urinalysis macro (dipstick) panel - Urine
3689
24479
2.89
241.11
8.6
4.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2150
11814
2.43
195.00
5.3
4.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1231
5194
2.81
193.77
7.8
6.2
mmol/l
105.4
104.5
9.15
1213
5029
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
684
2084
3.63
187.06
3.6
1.4
ug/l
40.5
4.5
1.23
571
1581
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1595
7901
2.49
178.92
3.2
2.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2776
17593
2.28
174.12
8.0
3.8
umol/l
10.9
13.0
15.82
2670
16444
(3024561) Albumin [Mass/volume] in Serum or Plasma
2459
15710
2.10
140.26
5.9
3.9
g/l
33.2
34.7
26.24
2292
14284
(3013826) Glucose [Moles/volume] in Serum or Plasma
3160
22360
2.10
134.56
6.5
4.6
mmol/l
7.0
7.0
0.44
3034
20967
(3009343) pH of Capillary blood
722
2854
2.78
124.21
5.0
3.7
ph
7.4
7.4
1.28
82
355
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
728
2899
2.76
123.43
5.0
3.7
kpa
5.0
5.1
3.68
684
2654
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1119
5487
2.33
121.79
4.6
2.5
mmol/l
0.8
0.8
7.53
1049
4988
(3009261) Glucose [Presence] in Urine by Test strip
2590
17444
1.99
121.45
6.2
3.7
estimate
0.0
0.0
1.34
563
2841
(3035350) Ketones [Presence] in Urine by Test strip
2570
17272
1.99
121.16
6.1
3.6
estimate
0.0
0.0
0.50
589
2945
(3021601) Nitrite [Presence] in Urine by Test strip
2561
17195
1.99
121.03
8.1
4.8
estimate
0.0
0.0
0.00
584
2996
(3032080) INR in Blood by Coagulation assay
2544
17051
1.99
120.73
11.5
12.2
inr
1.3
1.4
8.14
667
4632
(3013650) Neutrophils [#/volume] in Blood by Automated count
2705
18589
1.98
118.61
10.4
5.8
e9/l
4.8
4.6
2.74
2368
15798
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
695
2768
2.75
117.47
4.9
3.6
mmol/l
0.6
1.8
12.32
532
1967
(3030981) Hyaline casts [#/volume] in Urine by Automated count
626
2376
2.86
115.88
6.3
2.6
e6/l
0.5
0.3
0.99
621
2333
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2474
16918
1.90
105.53
7.6
5.5
mmol/l
1.2
1.2
1.36
2245
14868
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2662
18658
1.90
105.04
8.5
5.9
mmol/l
1.2
1.2
2.13
2250
15531
(3000991) Gas panel - Venous blood
769
3394
2.49
104.61
9.3
7.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
780
3484
2.46
103.30
6.0
3.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3473
26719
1.96
101.32
10.1
5.4
u/l
84.8
77.6
10.09
3310
24560
(3022313) Gas panel - Capillary blood
543
2058
2.83
100.16
5.2
3.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
992
5035
2.20
96.98
6.1
5.6
mmol/l
1.0
1.0
0.03
930
4585
(3002032) Base excess in Venous blood by calculation
866
4251
2.25
91.43
4.7
3.7
mmol/l
1.4
1.8
3.08
715
3382
(3021447) Carbon dioxide [Partial pressure] in Venous blood
865
4266
2.24
90.19
4.8
3.6
kpa
5.8
5.8
0.08
842
4110
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
630
2711
2.51
89.68
2.4
1.9
g/l
0.2
0.2
3.58
577
2431
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
459
1693
2.88
88.70
5.5
4.2
mmol/l
23.9
24.7
6.58
435
1534
(3014111) Lactate [Moles/volume] in Serum or Plasma
754
3634
2.26
82.58
7.8
6.1
mmol/l
1.4
1.4
0.88
728
3461
(3020779) Urea [Moles/volume] in Serum or Plasma
792
3898
2.22
82.41
6.2
6.7
mmol/l
11.6
12.1
0.91
733
3640
(3033658) Prothrombin time (PT) actual/Normal
1382
8433
1.88
78.50
5.3
3.6
%
83.9
79.5
8.24
1361
8220
(42870588) Differential panel, method unspecified - Blood
1756
11540
1.80
78.26
5.5
5.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1710
11242
1.78
75.49
4.6
2.1
mmol/l
2.3
2.3
1.25
1455
9199
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
818
4219
2.12
75.00
3.7
2.5
u/l
232.9
243.7
1.33
769
3881
(3019069) Monocytes/100 leukocytes in Blood
2214
15710
1.73
74.33
6.1
5.6
%
9.0
9.1
0.17
2072
14403
(3006504) Eosinophils/100 leukocytes in Blood
2205
15645
1.72
73.92
5.9
5.3
%
2.7
3.0
7.65
2062
14294
(3002030) Lymphocytes/100 leukocytes in Blood
2239
15987
1.72
73.08
6.1
5.5
%
23.7
25.4
10.34
2088
14574
(3022096) Basophils/100 leukocytes in Blood
2154
15226
1.72
72.89
5.9
5.3
%
0.6
0.6
4.18
2019
13936
(3041096) Erythrocytes [Presence] in Urine by Automated
1389
8693
1.82
71.60
5.7
3.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
499
2141
2.47
70.75
9.5
9.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
248
724
3.54
70.71
3.5
1.8
u/ml
449.0
101.7
0.62
219
581
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1683
11216
1.75
69.59
3.4
2.3
u/l
60.6
61.5
0.16
1574
10283
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
465
1964
2.50
68.11
4.7
4.0
mmol/l
23.6
24.0
2.59
425
1725
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
494
2162
2.42
66.93
9.9
8.2
mmol/l
23.4
24.3
9.78
468
1935
(3018010) Neutrophils/100 leukocytes in Blood
2190
15802
1.68
66.78
5.9
5.3
%
60.7
59.1
6.82
2053
14500
(3002173) Hemoglobin [Mass/volume] in Arterial blood
765
4056
2.04
64.36
8.7
7.2
g/l
117.0
122.9
13.16
746
3907
(3013115) Eosinophils [#/volume] in Blood
2352
17432
1.65
63.57
5.7
5.2
e9/l
0.2
0.2
2.87
2006
14923
(3016502) Oxygen saturation in Arterial blood
834
4590
1.97
63.03
8.3
6.7
%
96.0
94.8
8.34
805
4415
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
127
242
5.34
63.03
2.0
1.2
ug/l
24.3
21.9
0.20
121
234
(3027801) Oxygen [Partial pressure] in Arterial blood
897
5063
1.93
62.93
8.0
6.5
kpa
12.8
11.2
15.84
846
4793
(3003396) Base excess in Arterial blood by calculation
895
5049
1.93
62.89
8.0
6.5
mmol/l
-0.1
1.2
14.80
711
3830
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
897
5065
1.93
62.85
8.1
6.5
kpa
5.1
5.0
0.71
852
4803
(3006315) Basophils [#/volume] in Blood
2291
16907
1.65
62.68
5.6
5.0
e9/l
0.0
0.0
0.79
1934
14302
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
552
2622
2.24
61.62
9.7
8.1
%
0.5
0.7
17.42
542
2597
(3001604) Monocytes [#/volume] in Blood
2271
16771
1.64
61.61
5.6
5.0
e9/l
0.7
0.6
4.71
1913
14147
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
552
2644
2.22
60.31
9.5
8.0
%
1.1
1.4
7.75
542
2623
(3019198) Lymphocytes [#/volume] in Blood
2306
17190
1.62
59.53
5.7
5.1
e9/l
1.8
1.8
0.66
1982
14761
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
369
1493
2.58
58.93
3.0
2.8
u/ml
0.3
0.3
0.01
191
877
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
102
173
5.98
57.30
1.5
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
535
2623
2.16
54.91
1.6
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1236
7986
1.72
54.61
1.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1862
13386
1.62
54.26
7.0
3.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3990
34473
1.75
54.25
26.5
15.6
mg/l
35.1
27.5
31.09
3602
27908
(40768800) Prostate Pathology biopsy report
159
416
3.90
53.17
1.2
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
118
252
4.76
51.36
1.4
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
68
86
7.98
50.08
1.2
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
280
1076
2.69
49.48
3.4
3.0
kpa
8.2
7.7
4.77
261
998
(1616796) Gas panel - Central venous blood
255
964
2.73
46.50
3.6
3.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
450
2198
2.14
46.35
7.0
7.2
mmol/l
24.3
24.7
1.38
444
2170
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1467
10421
1.57
42.54
2.4
2.3
mg/l
3.1
3.0
0.80
1240
8694
(3015235) Bicarbonate [Moles/volume] in Capillary blood
298
1272
2.42
42.24
3.7
3.1
mmol/l
23.6
24.7
3.83
268
1125
(3036481) Cortisol [Moles/volume] in Serum or Plasma
483
2521
2.01
41.47
3.8
1.7
nmol/l
396.8
365.1
2.38
452
2246
(3018677) aPTT in Platelet poor plasma by Coagulation assay
988
6417
1.67
41.24
2.3
1.9
s
30.1
30.4
0.85
971
6213
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
888
5610
1.70
41.14
2.9
2.8
%
20.3
22.4
4.63
734
4663
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3690
32024
1.56
40.70
27.3
14.6
ml/min/173m2
67.9
71.8
24.07
3315
25927
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1069
7137
1.63
39.85
2.0
1.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
927
5971
1.67
39.79
2.8
2.6
g/l
2.2
2.2
0.05
836
5456
(3011397) Hemoglobin [Presence] in Urine by Test strip
1236
8567
1.58
39.32
6.0
3.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
1473
10643
1.54
38.88
4.6
3.4
ph
7.4
7.4
1.57
304
1887
(3024354) Oxygen [Partial pressure] in Venous blood
607
3534
1.81
37.16
3.6
3.1
kpa
4.3
4.4
0.87
582
3389
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
473
2553
1.94
36.70
1.6
1.5
—
—
—
0
0
(3013512) EKG study
1601
11892
1.50
36.62
5.3
4.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
489
2672
1.91
36.57
1.8
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
834
5342
1.67
36.25
2.0
2.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
973
6486
1.62
36.06
2.8
2.6
umol/l
11.3
12.4
5.87
892
5905
(40761536) Microorganisms panel - Urine sediment
498
2750
1.89
36.04
6.7
4.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
369
1842
2.08
35.67
1.8
1.8
ug/l
2.2
1.9
0.22
318
1595
(3019225) pH of Specimen
644
3861
1.76
35.61
5.4
3.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3949
35150
1.56
35.51
26.4
15.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1355
9789
1.52
35.09
7.1
4.0
estimate
0.0
0.0
0.09
503
2809
(3021901) Oxygen saturation in Capillary blood
228
938
2.49
34.97
3.3
2.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1781
13642
1.47
34.41
3.2
2.9
ug/l
164.8
159.5
0.42
1608
12293
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2751
22874
1.44
34.20
5.4
4.1
ug/l
3.3
2.7
0.71
2362
20288
(3019550) Sodium [Moles/volume] in Serum or Plasma
4094
36834
1.59
34.14
32.5
19.3
mmol/l
139.3
139.7
21.08
4011
35723
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
127
386
3.34
34.01
1.1
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
4098
36901
1.58
33.80
32.7
19.4
mmol/l
4.1
4.0
10.35
4011
35735
(40758558) Short blood count panel - Blood
1113
7770
1.55
33.50
8.4
4.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
976
6634
1.58
32.98
3.9
2.2
mmol/l
2.5
2.4
12.10
851
5604
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1372
10052
1.50
32.81
3.4
2.5
u/l
39.5
38.9
0.05
1293
9408
(3009542) Hematocrit [Volume Fraction] of Blood
3371
29243
1.46
32.46
27.6
17.2
%
37.1
38.9
14.10
1968
17504
(3021589) Normoblasts [#/volume] in Blood
1884
14766
1.44
31.45
13.8
9.2
e9/l
0.0
0.0
0.01
1524
11995
(3045414) Leukocytes [Presence] in Urine
316
1571
2.07
30.82
3.2
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
641
3996
1.69
30.50
5.2
3.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
579
3522
1.72
30.14
2.7
2.2
umol/l
9.7
9.2
0.12
507
3054
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
291
1415
2.12
30.09
3.0
2.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
484
2826
1.78
29.04
2.7
2.2
u/l
38.3
37.9
0.04
415
2344
(3004119) Hemoglobin [Mass/volume] in Venous blood
483
2838
1.77
28.34
4.4
3.3
g/l
124.7
130.2
5.50
472
2759
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
319
1653
1.99
27.71
2.2
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
134
478
2.85
27.32
2.6
2.8
%
1.3
1.5
0.18
97
354
(40767503) Oxygen content in Capillary blood by calculation
206
906
2.32
27.26
2.9
2.6
%
16.2
16.3
0.19
140
503
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
26
20
13.03
27.04
7.5
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
140
515
2.76
26.95
5.2
6.0
mg/l
12.9
12.2
0.95
125
466
(3007461) Platelets [#/volume] in Blood
4120
37634
1.51
26.78
39.2
22.6
e9/l
239.9
230.7
13.50
4006
36246
(3024731) MCV [Entitic volume]
4120
37642
1.51
26.67
39.1
22.5
fl
91.9
91.9
0.29
4044
36748
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
122
419
2.95
26.65
2.9
1.7
u/ml
210.2
725.9
0.67
107
384
(3026361) Erythrocytes [#/volume] in Blood
4120
37645
1.51
26.63
39.2
22.6
e12/l
4.3
4.5
66.41
3988
36066
(3000963) Hemoglobin [Mass/volume] in Blood
4120
37647
1.51
26.60
39.5
22.7
g/l
128.7
136.0
126.72
4039
36757
(3035941) MCH [Entitic mass]
4119
37641
1.51
26.53
39.0
22.5
pg
30.4
30.6
16.88
4041
36749
(3010813) Leukocytes [#/volume] in Blood
4120
37653
1.51
26.52
39.2
22.6
e9/l
7.5
7.0
28.23
3994
36083
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
333
1790
1.92
25.97
2.3
1.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
418
2414
1.79
25.94
4.7
3.3
mmol/l
24.5
25.0
2.24
407
2323
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2131
17463
1.38
25.85
2.3
2.1
pmol/l
91.2
91.1
0.05
1297
9498
(3000330) Specific gravity of Urine by Test strip
388
2204
1.82
25.43
6.8
3.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
432
2553
1.75
24.75
4.4
3.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2979
25859
1.37
24.57
4.3
4.1
mm/h
17.4
13.3
24.12
2686
23484
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3983
36370
1.45
23.72
13.4
9.5
u/l
25.4
25.6
0.22
3816
34503
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2362
19872
1.35
23.35
3.5
3.0
u/l
62.7
54.3
2.69
2155
17867
(3009214) Lutropin [Units/volume] in Serum or Plasma
132
519
2.58
22.33
1.3
1.3
u/l
13.0
8.1
3.62
108
414
(3044889) 12 lead EKG panel
2902
25359
1.33
21.35
4.8
4.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
106
384
2.79
21.08
3.0
2.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
444
2760
1.66
21.04
3.7
3.5
%
0.9
0.8
0.08
162
648
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
174
798
2.22
20.89
1.6
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
428
2654
1.67
20.46
3.6
3.6
%
0.1
0.1
0.22
158
601
(3023520) Reticulocytes [#/volume] in Blood
581
3884
1.56
20.34
2.3
2.1
e9/l
69.1
66.6
0.38
463
3003
(3007853) Bacteria identified in Skin by Aerobe culture
629
4289
1.53
20.12
1.9
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1881
15584
1.33
19.43
2.4
2.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
177
847
2.12
19.12
4.4
2.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
734
5226
1.47
18.94
2.4
2.0
%
1.8
1.7
1.41
637
4504
(3022145) Colonoscopy Study observation
490
3210
1.58
18.69
1.3
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
346
2091
1.70
18.20
1.7
1.5
g/l
1.8
1.5
4.30
303
1774
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1741
14368
1.32
18.14
3.2
3.3
ng/l
2373.7
1968.8
1.72
1518
12499
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
103
398
2.61
18.12
1.1
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
37
72
5.16
18.06
5.5
1.1
u/ml
18.0
33.7
—
10
15
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
698
4983
1.46
17.69
1.8
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
44
101
4.37
17.68
1.4
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
396
2498
1.63
17.65
3.6
3.4
%
0.7
0.5
0.65
121
473
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
457
2998
1.57
17.29
4.7
3.3
mmol/l
1.2
1.2
0.34
400
2539
(3037121) Protein [Mass/volume] in Urine
230
1258
1.86
17.01
3.0
2.4
g/l
0.4
0.3
0.31
120
470
(3022217) INR in Platelet poor plasma by Coagulation assay
912
6877
1.39
16.99
30.2
31.9
inr
1.4
1.6
3.00
137
919
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1947
16439
1.30
16.76
5.0
4.3
ng/l
48.0
90.6
2.76
1638
12871
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
693
4989
1.45
16.74
1.9
1.8
—
—
—
0
0
(3012501) Base excess in Blood by calculation
183
935
1.99
16.59
4.3
4.6
mmol/l
2.4
2.6
0.25
110
623
(3013290) Carbon dioxide [Partial pressure] in Blood
183
936
1.99
16.54
4.3
4.6
kpa
4.9
5.0
0.73
178
909
(40768795) Lymph node Pathology biopsy report
36
74
4.88
16.53
1.2
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
165
817
2.05
16.33
2.3
2.1
g/l
3.7
3.6
0.50
160
764
(3027315) Oxygen [Partial pressure] in Blood
183
941
1.98
16.30
4.3
4.6
kpa
8.3
8.3
0.17
178
913
(3006184) Hemoglobin [Mass/volume] in Capillary blood
196
1033
1.93
16.24
2.4
2.1
g/l
127.4
131.0
1.05
150
782
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
337
2091
1.65
16.03
3.0
2.5
%
0.7
0.7
0.02
325
1995
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
68
225
3.04
16.00
2.2
1.8
u/field
6.2
1.8
2.60
48
157
(3017354) Segmented neutrophils/100 leukocytes in Blood
86
324
2.68
15.95
2.6
2.7
%
65.0
60.5
0.90
53
207
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
170
864
2.00
15.66
1.4
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
387
2501
1.59
15.59
3.7
3.7
%
0.7
0.4
0.19
133
521
(3002385) Erythrocyte distribution width [Ratio]
3021
27120
1.28
15.42
32.8
18.5
%
14.2
13.8
30.76
2957
26351
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
351
2222
1.62
15.41
5.1
4.1
%
45.6
47.1
0.58
346
2185
(1761482) Bacteria [#/volume] in Urine by Culture
225
1263
1.81
15.33
7.7
3.9
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
28
50
5.61
15.01
1.4
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
91
368
2.49
14.65
3.8
3.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
365
2361
1.58
14.64
1.6
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1058
8354
1.33
14.42
4.5
4.3
ng/l
307.7
651.9
3.09
917
7341
(3017446) Testosterone [Moles/volume] in Serum or Plasma
384
2535
1.55
14.09
2.0
2.2
nmol/l
9.7
14.8
27.36
326
2143
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
89
365
2.46
13.93
2.5
2.1
u/field
3.5
1.5
0.94
41
136
(3023323) Follitropin [Units/volume] in Serum or Plasma
61
206
2.98
13.90
1.4
1.2
iu/l
32.7
23.9
1.12
49
171
(3021879) Hepatitis B virus core Ab [Presence] in Serum
234
1371
1.74
13.80
1.4
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
39
99
3.95
13.79
2.6
3.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
436
2974
1.51
13.75
3.9
2.6
ml/min/173m2
56.5
59.3
0.86
213
1204
(3007930) Methemoglobin/Hemoglobin.total in Blood
302
1900
1.62
13.60
5.4
4.9
%
0.9
0.9
0.01
289
1798
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
163
859
1.92
13.57
2.6
2.7
mg/l
1.9
1.9
0.04
138
739
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
65
232
2.82
13.42
1.3
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
119
562
2.14
13.40
1.6
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
205
1168
1.78
13.33
1.3
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
499
3523
1.46
13.24
2.4
1.6
g/l
65.6
66.5
1.82
441
3120
(3010421) pH of Blood
193
1083
1.81
13.20
4.2
4.5
ph
7.4
7.4
1.09
178
910
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
46
5.44
13.00
1.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
65
237
2.76
12.91
1.3
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
302
1929
1.60
12.79
5.3
4.9
%
1.7
1.6
0.60
289
1828
(3021960) Folate [Moles/volume] in Serum or Plasma
1253
10273
1.29
12.73
1.6
1.6
nmol/l
18.6
19.4
1.15
1057
8684
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
52
169
3.09
12.69
1.3
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
52
169
3.09
12.69
1.3
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
345
2281
1.55
12.58
1.7
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
412
2845
1.48
12.22
4.3
4.1
ng/l
110.8
105.4
0.38
339
2382
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1500
12631
1.26
12.16
3.2
2.9
ug/l
0.8
0.8
0.20
1102
9112
(3019060) Gas panel - Arterial blood
450
3172
1.46
12.02
5.0
4.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
91
405
2.26
11.91
1.3
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
90
399
2.27
11.88
1.3
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
90
401
2.26
11.75
1.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
90
404
2.24
11.55
1.3
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
89
400
2.24
11.39
1.3
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
46
149
3.10
11.32
2.3
1.9
e9/l
1.2
1.0
0.48
27
84
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
91
415
2.21
11.25
1.3
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1258
10506
1.26
10.69
3.1
2.7
umol/l
8121.9
6886.4
0.29
1049
8862
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
133
711
1.89
10.68
1.3
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
307
2055
1.52
10.59
2.3
2.1
g/l
10.5
11.1
1.53
287
1859
(3024928) Oxygen saturation in Venous blood
159
904
1.78
10.48
3.4
2.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
185
1099
1.70
10.45
4.3
3.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
95
461
2.08
10.07
1.3
1.5
—
—
—
0
0
(3036603) Volume of Urine
54
205
2.65
10.01
1.5
1.3
ml
1819.8
2020.5
0.55
31
54
(40768806) Pleura Pathology biopsy report
90
436
2.08
9.61
1.5
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
213
1347
1.60
9.47
3.1
1.5
ratio
1.1
2.6
—
10
104
(40760892) CBC W Ordered Manual Differential panel - Blood
822
6608
1.29
9.42
4.5
4.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
34
103
3.31
9.38
1.6
2.2
%
13.8
17.0
0.34
12
46
(46235355) HIV 1 and 2 tests - Meaningful Use set
401
2898
1.41
9.34
1.6
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
217
1396
1.58
8.99
3.1
1.5
mg/l
69.7
53.1
1.11
178
1117
(3042631) Mycobacterium sp identified in Specimen
106
559
1.91
8.94
2.5
2.9
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
216
1390
1.57
8.94
3.1
1.5
mg/l
55.7
43.5
0.72
177
1110
(3003434) Protein [Mass/volume] in Pleural fluid
114
616
1.87
8.93
1.4
1.5
g/l
31.3
28.9
1.21
97
541
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
183
1139
1.63
8.71
1.7
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1115
9383
1.24
8.58
1.8
1.8
nmol/l
1062.1
1138.3
2.04
807
7015
(21494814) CD8 cells/100 lymphocytes in Specimen
22
53
4.15
8.41
1.6
2.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
205
1325
1.57
8.34
6.2
6.0
mmol/l
1.3
1.4
0.16
181
1185
(3028308) Erythrocytes [#/volume] in Pleural fluid
95
495
1.93
8.33
1.3
1.5
e6/l
23366.9
76896.0
1.95
58
293
(3028026) IgM [Mass/volume] in Serum or Plasma
247
1664
1.51
8.32
1.6
1.4
g/l
1.3
1.1
0.68
226
1487
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
880
7252
1.26
8.13
1.8
1.6
mg/l
1.8
1.4
1.66
727
5654
(3008152) Bicarbonate [Moles/volume] in Arterial blood
405
3011
1.37
7.98
7.7
6.8
mmol/l
24.0
24.4
1.10
378
2817
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1540
13468
1.20
7.96
2.2
2.1
nmol/l
77.4
77.9
0.27
1327
11515
(3022806) Fractional oxyhemoglobin in Capillary blood
97
521
1.87
7.79
2.0
1.9
%
89.1
89.2
0.06
97
515
(40760888) Immunoglobulin light chains.free panel - Serum
162
1015
1.61
7.55
2.9
1.5
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
152
938
1.64
7.54
7.0
6.8
mmol/l
105.5
105.1
0.53
139
853
(3039000) Anion gap in Blood
152
938
1.64
7.54
7.0
6.8
mmol/l
11.3
11.4
0.04
139
853
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
64
300
2.14
7.53
1.2
1.1
u/l
52.5
55.0
0.13
45
189
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
237
1623
1.48
7.40
2.6
2.2
ug/l
670.3
682.1
0.02
226
1529
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
201
1331
1.53
7.38
3.3
2.9
pmol/l
4.2
4.4
1.55
177
1143
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2040
18392
1.18
7.29
4.5
4.0
%
21.4
24.5
18.33
1086
9529
(3004588) Protein electrophoresis panel - Serum or Plasma
403
3043
1.35
7.20
2.3
1.5
—
—
—
0
0
(4024509)
72
361
2.00
7.11
1.5
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
46
194
2.38
6.96
4.0
4.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
303
2199
1.40
6.93
3.1
3.1
e9/l
4.5
4.3
0.64
204
1508
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
602
4836
1.27
6.84
4.7
5.1
%
32.2
33.0
0.94
387
3187
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3298
31017
1.18
6.72
4.7
4.2
mu/l
2.0
2.1
2.68
2893
27482
(3000570) Elastase.pancreatic [Mass/mass] in Stool
144
904
1.61
6.71
1.5
1.5
ug/g
223.4
273.9
2.05
83
556
(3023199) Leukocytes [#/volume] in Pleural fluid
97
548
1.78
6.68
1.3
1.5
e6/l
1061.5
2895.9
1.80
67
406
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
29
99
2.93
6.65
1.7
2.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1605
14273
1.18
6.59
4.1
4.1
mg/mmol
14.5
9.4
3.25
1123
9406
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
94
531
1.78
6.49
2.1
2.3
mg/l
30.5
23.9
0.36
22
128
(3011648) Oxygen content in Venous blood
59
286
2.07
6.42
1.6
2.0
%
9.8
11.2
1.50
59
286
(3033705) Calcium.ionized [Moles/volume] in Venous blood
109
645
1.70
6.40
2.7
2.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
36
141
2.56
6.40
2.1
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
28
96
2.92
6.38
1.3
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
30
109
2.76
6.17
1.9
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
192
1313
1.48
6.10
2.2
2.3
ug/min
174.8
109.3
0.65
111
776
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
86
483
1.79
6.08
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
67
348
1.93
6.04
1.5
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1066
9217
1.19
5.98
1.8
1.8
pmol/l
22880789.5
27257209.0
0.09
861
7422
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
64
329
1.95
5.95
1.2
1.3
nmol/l
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
295
2188
1.37
5.95
2.6
2.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1517
13518
1.17
5.95
3.2
3.2
mmol/l
7.2
7.7
5.14
1203
11157
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
10
16
6.24
5.93
1.0
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
29
106
2.74
5.91
2.6
1.5
e9/l
0.3
0.2
0.33
29
99
(3037756) Immunofixation for Serum or Plasma
137
880
1.57
5.84
1.3
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1505
13422
1.17
5.81
3.4
3.3
mg/l
408.7
214.8
1.08
1070
8959
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
17
45
3.78
5.78
1.8
2.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1454
12940
1.17
5.76
2.3
2.2
u/l
252.2
252.0
0.00
1361
12076
(3023183) Ammonium ion [Moles/volume] in Plasma
131
836
1.58
5.75
1.9
2.3
umol/l
31.2
33.8
0.61
105
693
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
90
523
1.73
5.69
1.3
1.6
iu/l
2.3
4.5
3.14
16
144
(3019150) Specific gravity of Urine by Refractometry
959
8257
1.20
5.60
7.7
4.0
kg/l
1.0
1.0
0.52
176
1260
(40768797) Stomach Pathology biopsy report
561
4588
1.25
5.47
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3589
34194
1.16
5.46
5.4
5.2
mmol/l
6.3
6.2
2.66
3152
30436
(3014271) Vancomycin [Susceptibility]
60
312
1.93
5.43
3.0
2.9
—
—
—
0
0
(3036489) Thrombin time
163
1108
1.48
5.38
2.2
1.8
s
22.1
21.7
0.25
155
993
(4281824)
30
118
2.55
5.33
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
31
124
2.50
5.33
3.4
2.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
57
295
1.94
5.25
1.1
1.2
miu/ml
157.1
201.2
0.48
15
83
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
31
125
2.48
5.24
2.5
1.6
e6/l
412.1
689.6
2.77
17
55
(3000494) Fungus identified in Specimen by Culture
476
3842
1.26
5.21
1.5
1.4
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
0
+∞
5.20
1.0
0.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
0
+∞
5.20
1.0
0.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
70
389
1.81
5.18
1.3
1.2
u/ml
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3482
33150
1.16
5.16
7.2
6.9
mmol/mol
42.2
41.6
2.60
3120
30137
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
76
434
1.76
5.14
3.7
3.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
31
127
2.44
5.08
2.1
2.2
%
33.7
46.2
—
7
18
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
94
572
1.65
5.06
3.8
3.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2614
24421
1.14
5.05
3.8
3.4
pmol/l
15.0
15.0
0.03
2272
21502
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
67
374
1.80
4.91
1.2
1.3
nmol/l
0.7
3.4
0.49
61
360
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
221
1618
1.38
4.89
2.5
1.4
g/l
9.9
10.5
1.21
177
1335
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
231
1719
1.36
4.63
2.5
1.4
g/l
7.4
7.4
0.05
160
1245
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
231
1719
1.36
4.63
2.5
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
230
1713
1.36
4.59
2.5
1.4
g/l
4.0
3.9
0.49
159
1212
(3045788) Cell count panel - Pleural fluid
71
414
1.72
4.51
1.4
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
61
341
1.79
4.48
1.2
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
77
466
1.66
4.29
7.0
5.1
iu/ml
1124.5
864.8
0.14
21
69
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
82
506
1.63
4.24
1.4
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
65
377
1.73
4.24
4.1
3.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
139
966
1.45
4.18
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
139
967
1.45
4.16
1.5
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
187
1373
1.37
4.12
1.2
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
17
57
2.98
4.10
1.3
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
17
57
2.98
4.10
3.3
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
86
542
1.59
4.09
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
113
759
1.50
4.05
1.5
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
120
816
1.48
4.05
1.6
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
44
230
1.92
4.02
1.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
98
641
1.54
3.98
1.6
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
191
1418
1.36
3.94
2.6
1.5
g/l
1.0
0.6
0.90
153
1186
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
90
579
1.56
3.94
1.4
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
65
1055
0.61
3.90
1.3
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
14
43
3.25
3.88
1.4
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
23
94
2.45
3.85
1.4
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
211
1597
1.33
3.84
2.6
1.4
g/l
3.2
3.0
1.30
161
1238
(3021387) Prolactin [Units/volume] in Serum or Plasma
70
427
1.64
3.82
1.6
1.8
mu/l
308.1
274.2
0.37
70
392
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
115
786
1.47
3.81
1.6
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
82
522
1.58
3.77
1.5
1.4
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
6
5
11.98
3.75
1.0
2.0
umol/l
344.2
150.0
—
6
5
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
89
580
1.54
3.70
1.6
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
34
168
2.03
3.66
1.5
1.4
%
59.0
66.3
0.66
26
138
(3037692) Legionella sp identified in Specimen by Organism specific culture
25
110
2.27
3.59
2.0
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
123
863
1.43
3.58
1.4
1.2
titre
172.0
250.6
—
5
17
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
34
170
2.00
3.56
1.1
1.1
u/l
75.1
89.0
0.58
24
130
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
25
111
2.25
3.52
1.4
1.3
nmol/l
0.2
0.2
0.19
20
88
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
14
46
3.04
3.51
1.1
2.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
34
171
1.99
3.50
1.1
1.1
u/l
16.5
26.6
1.19
24
123
(3006462) Nitrate [Presence] in Urine
36
185
1.95
3.49
4.8
3.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
103
702
1.47
3.49
1.1
1.2
u/l
29.7
26.7
0.14
91
598
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
47
264
1.78
3.48
1.4
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
229
1785
1.29
3.41
2.2
1.5
u/ml
25.3
19.5
0.23
12
50
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
179
1350
1.33
3.38
2.2
1.4
g/l
36.7
37.4
0.63
144
1122
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
42
231
1.82
3.34
2.0
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
71
455
1.56
3.23
1.2
1.2
—
—
—
0
0
(4034850)
94
1350
0.69
3.23
16.4
11.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
42
235
1.79
3.18
3.5
2.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
47
272
1.73
3.17
6.7
10.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
49
2.85
3.17
1.5
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
44
250
1.76
3.16
1.3
1.1
—
—
—
0
0
(4211845)
38
207
1.84
3.13
4.6
3.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
17
67
2.54
3.10
2.1
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
63
397
1.59
3.09
1.6
1.5
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
8
7.49
3.05
1.0
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
96
665
1.45
3.04
1.3
1.3
mmol/l
54.2
64.8
2.32
80
527
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
180
1382
1.31
3.04
1.8
1.5
titre
72.5
229.1
—
8
71
(3044927) Protein electrophoresis panel - Urine
78
521
1.50
2.97
1.1
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
83
563
1.48
2.94
3.7
20.7
mmol/l
7.9
7.7
0.16
71
457
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
164
1254
1.31
2.87
1.2
1.2
iu/ml
101.3
108.8
0.09
36
447
(3018405) Lactate [Moles/volume] in Arterial blood
213
1695
1.26
2.76
4.3
3.9
mmol/l
1.4
1.5
0.74
207
1658
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
6
8.32
2.74
6.2
1.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
20
91
2.20
2.71
1.5
2.4
e6/l
22061.6
26128.8
0.06
12
54
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
56
356
1.58
2.69
2.5
2.3
u/ml
1692.8
500.7
—
6
25
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
25
126
1.98
2.63
1.6
1.4
u/l
15.1
2397.9
—
10
38
(3008295) Osmolality of Serum or Plasma
49
304
1.61
2.61
1.3
1.3
mosm/kgh2o
282.0
277.7
0.45
35
218
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
32
177
1.81
2.57
1.4
1.4
u/l
2.9
6.4
1.12
14
73
(3012565) Volume of 24 hour Urine
31
170
1.82
2.56
1.5
2.2
ml
2011.9
1916.9
0.20
16
141
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
75
515
1.46
2.54
1.5
1.4
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
5
7
7.13
2.54
1.8
1.1
ng/l
239.0
204.7
—
5
7
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
80
559
1.43
2.49
3.3
3.3
%
61.2
60.0
0.31
80
559
(3004775) Volume in Urine collected for unspecified duration
65
436
1.49
2.48
1.8
2.3
ml
796.3
656.6
1.30
32
287
(3043409) Potassium [Moles/volume] in Arterial blood
183
1452
1.27
2.46
4.7
4.2
mmol/l
4.1
4.0
1.98
163
1345
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
37
217
1.71
2.45
1.3
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
37
218
1.70
2.42
1.3
1.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
27
145
1.86
2.39
1.6
1.4
%
2.9
2.6
0.08
21
121
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
9
28
3.21
2.30
1.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
43
268
1.61
2.29
1.1
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
18
85
2.12
2.27
1.3
1.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
19
92
2.06
2.25
1.8
2.1
u/ml
1881.2
28205.2
—
6
15
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
25
134
1.87
2.24
1.8
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
25
134
1.87
2.24
1.8
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
25
134
1.87
2.24
1.8
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
25
134
1.87
2.24
1.7
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
28
156
1.79
2.23
1.4
1.4
pmol/l
139.6
71.4
1.16
28
151
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
24
128
1.87
2.19
1.3
1.2
ug/l
1629.0
64.0
0.94
19
52
(3023487) Leukocytes [#/volume] in Peritoneal fluid
21
107
1.96
2.18
1.5
2.4
e6/l
1854.6
722.5
0.56
15
80
(3020891) Body temperature
225
1859
1.22
2.14
5.4
4.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
19
94
2.02
2.14
1.7
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
20
101
1.98
2.13
3.0
2.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
119
913
1.31
2.12
1.5
1.6
iu/ml
13.1
6.6
0.29
33
223
(3030905) Polymorphonuclear cells [#/volume] in Blood
76
544
1.40
2.12
3.0
3.1
e9/l
5.1
4.6
0.68
76
544
(3045142) Bone marrow Pathology biopsy report
44
282
1.56
2.11
1.1
1.1
—
—
—
0
0
(44806420)
28
159
1.76
2.11
2.4
2.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
449
3940
1.15
2.10
1.3
1.3
titre
361.4
514.8
2.29
87
883
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
19
95
2.00
2.09
1.7
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
19
95
2.00
2.09
1.7
1.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
20
102
1.96
2.08
2.2
2.6
mmol/l
9.4
8.2
0.17
14
65
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
50
736
0.67
2.08
1.6
1.7
mg/l
5.3
3.6
0.51
40
511
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
41
261
1.57
2.03
2.0
2.2
ug/min
30.9
228.5
—
9
72
(3016650) Hepatitis A virus Ab [Presence] in Serum
57
390
1.46
2.03
1.0
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
15
3.99
2.03
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3572
34737
1.09
2.02
5.2
5.6
mmol/l
2.4
2.5
2.03
3131
31450
(3048929) Epstein Barr virus Ab [Presence] in Serum
72
516
1.40
2.01
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
192
1573
1.23
2.00
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
45
294
1.53
2.00
1.4
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
26
147
1.77
2.00
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
26
147
1.77
2.00
1.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
64
893
0.71
2.00
1.6
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
37
231
1.60
1.99
1.4
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
59
409
1.44
1.98
1.2
1.2
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
15
70
2.14
1.96
2.5
2.5
ml/dl
14.8
15.1
0.12
15
63
(3011985) Renin [Units/volume] in Plasma
60
418
1.44
1.96
1.3
1.3
mu/l
76.8
77.8
0.01
53
367
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
16
77
2.08
1.95
1.1
1.2
pmol/l
155.6
251.9
—
8
52
(3000093) Morphology [Interpretation] in Blood Narrative
57
394
1.45
1.94
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
79
579
1.37
1.94
1.8
2.5
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
24
134
1.79
1.93
1.4
1.4
%
20.7
23.2
0.18
19
119
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
14
64
2.19
1.93
3.6
2.5
u/field
0.1
0.4
0.94
14
64
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
55
379
1.45
1.91
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
48
322
1.49
1.90
1.3
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
16
78
2.05
1.89
1.3
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
109
842
1.30
1.88
1.3
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
520
4645
1.13
1.88
2.5
2.5
ug/l
5.2
7.8
4.79
429
3997
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
157
1269
1.24
1.88
2.4
1.5
g/l
0.1
0.0
0.50
141
1135
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
47
315
1.49
1.88
1.4
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
38
243
1.56
1.87
3.2
4.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
34
2.64
1.85
1.1
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
16
79
2.02
1.84
2.2
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
148
1193
1.24
1.82
2.5
1.5
g/l
0.0
0.0
0.00
133
1064
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
63
450
1.40
1.82
1.5
1.4
—
15.6
—
0
11
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
56
393
1.43
1.79
1.5
1.5
u/ml
111.1
128.0
0.42
14
74
(21494890) Protein electrophoresis panel - 24 hour Urine
58
410
1.42
1.78
2.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
63
452
1.40
1.78
1.5
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
88
666
1.32
1.78
1.4
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
145
1171
1.24
1.77
2.5
1.5
g/l
0.0
0.0
0.00
132
1059
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
13
60
2.16
1.76
11.8
13.7
mmol/l
4.8
5.1
0.26
13
60
(3007566) Smooth muscle Ab [Titer] in Serum
96
738
1.30
1.74
1.2
1.1
titre
68.6
123.0
—
7
54
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
118
932
1.27
1.74
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
305
2645
1.16
1.72
1.6
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
109
854
1.28
1.72
1.3
1.4
g/l
0.2
0.2
0.46
94
805
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
38
249
1.53
1.71
2.2
2.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
26
155
1.68
1.70
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
48
2.29
1.69
1.6
1.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
14
68
2.06
1.69
1.6
1.4
%
3.7
5.8
—
6
31
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
111
875
1.27
1.68
1.3
1.4
g/l
1.1
1.1
0.27
98
821
(3007164) IgA [Mass/volume] in Serum or Plasma
550
4970
1.12
1.66
1.4
1.3
g/l
3.0
2.9
0.22
334
2783
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
161
1327
1.22
1.64
1.6
1.6
u/l
33.9
37.2
1.21
136
1098
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
46
318
1.45
1.62
1.1
1.1
iu/ml
3.1
2.2
—
7
14
(3003338) MCHC [Mass/volume]
2849
27581
1.07
1.61
35.0
20.6
g/l
330.4
332.5
27.46
2809
27237
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
32
2.50
1.59
3.5
2.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
103
811
1.27
1.59
1.3
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
82
627
1.31
1.58
1.1
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
50
2.20
1.56
1.0
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3458
33730
1.07
1.53
4.7
4.9
mmol/l
4.2
4.3
1.68
3037
30667
(3029075) Extractable nuclear Ab panel - Serum
15
78
1.92
1.53
1.0
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
412
4573
0.89
1.51
1.3
1.2
u/ml
28.5
16.2
0.38
113
1607
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
23
138
1.67
1.50
1.0
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
41
282
1.45
1.50
2.4
2.1
ph
7.4
7.4
0.24
18
108
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
86
1.86
1.49
1.0
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
22
131
1.68
1.48
1.8
1.5
umol/l
139.4
116.8
0.15
13
75
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3319
32347
1.07
1.47
4.2
4.4
mmol/l
1.4
1.3
11.55
2867
28905
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
23
139
1.65
1.46
2.7
2.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
10
45
2.22
1.45
1.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
38
2.36
1.45
1.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
16
3.12
1.43
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
59
2.03
1.42
1.8
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
25
156
1.60
1.42
1.0
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
25
156
1.60
1.42
1.0
1.3
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
26
164
1.58
1.41
1.3
3.4
mg/l
51.4
82.3
1.79
17
112
(3026480) Teichoate Ab [Titer] in Serum
9
40
2.25
1.39
1.1
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3419
33383
1.07
1.39
4.7
4.9
mmol/l
1.3
1.4
6.95
2986
30081
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
21
126
1.67
1.38
1.9
1.9
%
88.0
89.4
0.05
21
117
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
37
0.00
1.34
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
12
61
1.96
1.31
1.3
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
38
532
0.71
1.31
1.3
1.3
—
—
—
0
0
(44790048)
50
367
1.36
1.31
1.8
1.4
—
—
—
0
0
(44790047)
50
367
1.36
1.31
1.8
1.4
—
—
—
0
0
(44806118)
50
367
1.36
1.31
1.8
1.4
—
—
—
0
0
(44790049)
50
367
1.36
1.31
1.8
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
61
464
1.32
1.27
1.9
1.7
g/l
0.9
1.0
0.12
43
359
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
21
328
0.64
1.26
1.0
1.0
ng/l
46.5
44.7
0.09
13
196
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
21
328
0.64
1.26
1.0
1.0
ng/l
630.3
692.0
0.32
11
198
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
9
44
2.04
1.26
1.3
1.0
—
—
—
0
0
(4146454)
68
526
1.29
1.26
2.2
2.7
—
—
—
0
0
(3048879) Bone marrow aspiration report
17
99
1.72
1.26
1.2
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
21
327
0.64
1.25
1.0
1.0
ng/l
380.5
320.6
0.67
13
201
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
51
379
1.35
1.24
1.2
1.3
u/ml
246.2
295.2
0.49
24
243
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
448
4881
0.91
1.20
1.2
1.3
iu/ml
39.1
41.2
0.09
149
1467
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
61
469
1.30
1.19
1.5
1.5
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
52
391
1.33
1.19
1.1
1.3
pmol/l
266.0
251.9
0.17
42
290
(3032057) Clostridioides difficile [Presence] in Stool
17
101
1.68
1.18
3.1
1.8
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
38
2.10
1.18
1.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
36
255
1.41
1.18
1.8
1.8
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
12
64
1.87
1.17
2.2
2.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
40
290
1.38
1.15
1.8
2.0
min
498.9
494.0
0.08
18
215
(4010399)
294
2627
1.12
1.15
1.5
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
20
2.50
1.15
1.2
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
30
2.33
1.12
1.3
1.0
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
11
58
1.89
1.11
1.4
1.1
ug/l
57.6
144.4
—
5
32
(3034092) Cytoplasmic Ig cells/100 cells in Blood
7
31
2.25
1.10
4.0
11.9
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
14
81
1.73
1.08
1.0
1.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
7
32
2.18
1.07
1.0
1.1
mmol/l
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
7
32
2.18
1.07
1.0
1.1
mmol/l
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
16
97
1.65
1.05
2.6
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
180
2047
0.87
1.04
1.2
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
90
740
1.22
1.04
1.2
1.1
titre
360.0
1347.6
—
6
21
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
22
2.27
1.03
1.6
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
35
254
1.38
1.03
1.5
1.3
—
—
—
0
0
(3025315) Body weight
7
34
2.05
1.02
4.6
5.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
22
146
1.51
1.02
1.1
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
114
963
1.18
1.00
4.0
3.7
mg/l
38.9
30.1
1.37
70
673
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
53
412
1.29
0.99
1.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
35
2.00
0.99
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
312
2826
1.11
0.99
1.3
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
16
99
1.61
0.99
1.0
1.0
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
15
92
1.63
0.96
47.7
33.6
ug/l
6.9
7.4
0.34
15
83
(3006270) Folate [Moles/volume] in Blood
52
406
1.28
0.95
1.2
1.2
nmol/l
280.8
315.3
0.61
37
307
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
120
1024
1.17
0.95
1.6
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
322
2931
1.10
0.94
1.5
1.7
%
1.7
1.6
0.22
261
2407
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
73
595
1.23
0.94
1.4
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
41
532
0.77
0.93
1.4
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
31
225
1.38
0.93
1.1
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
52
1.73
0.92
1.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
41
312
1.31
0.91
1.1
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
28
2.14
0.91
1.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
15
94
1.59
0.89
1.1
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
38
288
1.32
0.88
1.4
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
12
71
1.69
0.88
1.9
1.5
ng/l
189.8
135.6
0.54
12
71
(3041918) Cholesterol [Moles/volume] in Pleural fluid
12
71
1.69
0.88
1.2
1.2
mmol/l
1.0
1.2
—
7
41
(3001964) Herpes simplex virus Ag [Presence] in Specimen
13
79
1.64
0.87
2.7
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
157
1379
1.14
0.86
1.3
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
14
87
1.61
0.86
1.1
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
10
167
0.60
0.85
2.7
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
25
178
1.40
0.85
1.3
1.1
nmol/l
146.9
142.3
0.15
25
178
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
36
273
1.32
0.84
1.6
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
36
273
1.32
0.84
1.6
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
36
273
1.32
0.84
1.6
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
11
65
1.69
0.81
2.3
2.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
32
1.87
0.81
1.5
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
25
181
1.38
0.78
2.7
2.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
96
0.52
0.78
10.2
7.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
26
190
1.37
0.77
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
26
190
1.37
0.77
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
26
190
1.37
0.77
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
32
242
1.32
0.77
1.2
1.2
mmol/l
14.0
11.7
0.64
13
71
(3019174) dRVVT (LA screen)
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
22
157
1.40
0.75
1.3
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
66
548
1.20
0.75
1.6
1.5
%
62.3
64.9
0.22
42
357
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
9
53
1.69
0.75
1.1
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
15
99
1.51
0.74
1.3
1.5
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
24
2.08
0.74
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
24
2.08
0.74
1.2
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
24
2.08
0.74
1.2
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
52
422
1.23
0.74
3.2
3.2
mg/l
123.2
39.2
0.55
46
326
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
25
334
0.75
0.73
1.1
1.2
mmol/l
8.1
8.0
0.07
18
228
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
7
38
1.84
0.73
2.3
2.0
—
39.4
—
0
8
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
38
1.84
0.73
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
124
1403
0.88
0.73
1.9
1.9
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
5
25
2.00
0.72
1.2
1.6
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
880
9158
0.95
0.72
1.6
1.6
mmol/l
1.4
1.3
2.38
726
7491
(3021788) Differential panel - Synovial fluid
90
772
1.17
0.72
1.6
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
26
193
1.35
0.72
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
26
193
1.35
0.72
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
26
193
1.35
0.72
1.1
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
13
84
1.55
0.71
1.3
1.2
g/l
0.3
0.3
—
7
59
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
151
1.39
0.70
1.0
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
95
821
1.16
0.70
1.8
1.7
mg/l
11.8
12.0
0.11
85
754
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
27
203
1.33
0.69
1.0
1.0
mg/l
286.1
281.6
0.14
22
178
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
102
1164
0.87
0.69
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
27
204
1.32
0.67
1.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
138
1231
1.12
0.65
1.4
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
201
0.69
0.64
1.1
1.3
u/ml
2.8
1.3
—
8
112
(1761868) Lipid panel - Serum or Plasma
922
9553
0.95
0.64
3.4
3.5
—
—
—
0
0
(3000012) Reticulocyte production index
31
241
1.28
0.64
1.3
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
29
1.72
0.63
1.4
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
29
1.72
0.63
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
22
163
1.35
0.63
1.7
2.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
39
314
1.24
0.62
1.5
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
22
164
1.34
0.61
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
22
164
1.34
0.61
1.7
1.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
30
1.66
0.61
1.6
1.1
—
—
—
0
0
(4015189)
18
130
1.38
0.60
1.9
2.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
8
51
1.57
0.60
1.1
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
462
4363
1.06
0.60
3.3
3.3
ng/l
267.7
280.9
0.25
425
4038
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
112
0.62
0.58
8.0
7.9
—
—
—
0
0
(4212803)
6
35
1.71
0.57
1.2
1.0
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
5
86
0.58
0.56
1.2
1.2
mg/l
1.5
0.9
—
5
61
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
22
167
1.32
0.55
2.2
2.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
6
37
1.62
0.55
1.0
1.6
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
121
0.66
0.54
1.3
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
121
0.66
0.54
1.3
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
121
0.66
0.54
1.3
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
121
0.66
0.54
1.3
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
552
5762
0.95
0.54
1.2
1.2
u/ml
3.0
1.9
0.54
111
1468
(3044290) Cell count panel - Cerebral spinal fluid
69
598
1.15
0.53
1.3
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
36
294
1.22
0.53
1.0
1.1
—
24.6
—
0
5
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
222
1.26
0.52
1.7
1.7
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
34
276
1.23
0.52
1.1
1.2
promille
1.7
1.2
0.87
27
211
(3008898) HLA-B27 [Presence]
52
605
0.86
0.50
1.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
32
260
1.23
0.50
1.6
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
12
84
1.43
0.48
4.0
5.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
45
380
1.18
0.48
1.1
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
15
110
1.36
0.48
1.9
2.5
%
31.4
44.2
—
9
45
(3029634) Reagin Ab [Titer] in Serum by VDRL
29
354
0.82
0.47
1.7
2.0
—
3.1
—
0
7
(3024471) HLA-A [Type]
11
76
1.44
0.47
1.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
32
262
1.22
0.47
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
300
3169
0.94
0.47
1.5
1.5
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
36
299
1.20
0.46
1.5
1.4
g/l
3.0
3.1
0.12
22
217
(3024139) IgG subclass 3 [Mass/volume] in Serum
36
299
1.20
0.46
1.5
1.4
g/l
0.4
0.5
0.84
22
219
(3027135) IgG subclass 1 [Mass/volume] in Serum
36
299
1.20
0.46
1.5
1.4
g/l
7.0
7.1
0.05
22
216
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
68
1.47
0.46
1.5
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
33
272
1.21
0.46
1.1
1.1
—
98.2
—
0
10
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
20
155
1.29
0.46
1.1
1.3
—
—
—
0
0
(4062490)
36
300
1.20
0.45
1.5
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
69
607
1.14
0.45
1.1
1.1
—
—
—
0
0
(4027681)
8
120
0.66
0.45
1.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
128
0.70
0.43
7.3
8.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
20
157
1.27
0.42
1.3
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
78
1.41
0.42
1.1
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
33
275
1.20
0.42
1.1
1.2
—
48.9
—
0
21
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
32
1.56
0.42
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
32
1.56
0.42
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
32
1.56
0.42
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
32
1.56
0.42
1.4
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
150
0.73
0.42
1.2
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
147
1583
0.92
0.41
1.2
1.3
u/ml
342.0
268.2
0.30
137
1456
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.9
—
1.6
—
0
8
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
19
149
1.27
0.41
2.7
2.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
19
149
1.27
0.41
2.7
2.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
20
158
1.26
0.41
1.2
1.2
g/l
36.9
40.2
0.34
11
84
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
150
1.26
0.39
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
71
1.41
0.38
1.2
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
1.2
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
27
224
1.20
0.37
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
18
224
0.80
0.37
1.2
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
9
70
1.28
0.36
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
31
262
1.18
0.36
1.6
1.3
—
—
—
0
0
(4133840)
9
71
1.26
0.36
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
41
1.46
0.36
2.5
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
11
81
1.36
0.35
1.4
2.1
—
—
—
0
0
(4198724)
6
42
1.43
0.35
1.2
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
145
0.76
0.35
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
18
144
1.25
0.34
1.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
47
413
1.14
0.34
1.5
1.3
e6/l
15152.5
238821.2
5.05
33
294
(3010726) Horse dander IgE Ab [Units/volume] in Serum
22
181
1.21
0.33
1.0
1.1
u/ml
2.3
2.3
—
5
39
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
29
246
1.18
0.33
1.0
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
62
685
0.90
0.32
1.4
1.3
e6/l
18.0
23.2
0.18
41
545
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
62
685
0.90
0.32
1.5
1.4
e6/l
1129.7
704.1
0.29
44
576
(44813793)
13
165
0.79
0.32
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
98
902
1.09
0.32
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
19
155
1.22
0.31
1.1
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
11
83
1.32
0.31
1.1
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
309
2960
1.04
0.30
2.3
2.2
ug/g
188.7
183.0
0.07
242
2307
(3024932) HLA-DR beta [Type]
10
75
1.33
0.29
1.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
56
1.25
0.29
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
107
0.75
0.29
1.3
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
22
185
1.19
0.28
1.5
1.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
63
1.27
0.27
1.0
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
101
1078
0.93
0.26
1.3
1.2
u/ml
0.3
0.5
—
5
114
(3039443) Prostate specific Ag panel - Serum or Plasma
70
758
0.92
0.26
1.5
1.6
—
—
—
0
0
(1002224) Polysomnography panel
75
807
0.93
0.25
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
27
235
1.15
0.24
1.5
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
544
5293
1.03
0.24
10.9
8.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
97
907
1.07
0.24
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
77
714
1.08
0.24
1.2
1.2
u/ml
4.2
4.3
—
10
110
(3000764) Benzodiazepines [Presence] in Urine
27
236
1.14
0.23
1.5
1.8
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
5
38
1.31
0.23
1.2
1.5
%
0.8
0.7
—
5
30
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
76
706
1.07
0.23
1.2
1.2
u/ml
3.7
8.3
—
6
66
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
34
303
1.12
0.22
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
45
408
1.10
0.22
1.2
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
93
0.75
0.22
1.7
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
32
285
1.12
0.22
1.2
1.3
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
21
241
0.87
0.22
1.3
1.4
pmol/l
35.4
189.8
0.61
12
70
(3003327) Ova and parasites identified in Stool by Light microscopy
73
780
0.93
0.21
1.4
1.7
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(3012989) Citrate [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.4
—
2.3
—
0
11
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
5
42
1.19
0.21
1.2
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
27
238
1.13
0.21
1.5
1.8
—
—
—
0
0
(3013762) Body weight Measured
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
73
778
0.93
0.20
1.3
1.3
nmol/l
1.0
0.8
1.26
59
631
(3028300) Cannabinoids [Presence] in Urine
27
239
1.13
0.20
1.5
1.8
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
95
895
1.06
0.20
1.2
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
24
211
1.14
0.20
1.4
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
55
508
1.08
0.20
1.1
1.1
iu/ml
2.7
415.4
—
10
101
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
23
202
1.14
0.19
1.9
1.7
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
12
143
0.84
0.19
1.6
1.3
%
83.0
62.7
3.50
12
127
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
71
753
0.94
0.18
1.8
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
58
1.20
0.18
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
26
233
1.11
0.17
1.5
1.6
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
30
329
0.91
0.17
1.1
1.4
—
318.3
—
0
41
(3027923) C peptide [Moles/volume] in Serum or Plasma
25
224
1.11
0.16
1.2
1.3
nmol/l
1.2
1.2
0.09
20
163
(3025130) Human papilloma virus identified in Specimen
8
69
1.16
0.16
1.0
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
81
1.11
0.15
1.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
82
1.09
0.14
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
83
1.08
0.14
1.4
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
25
226
1.10
0.14
1.5
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
19
169
1.12
0.14
1.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
86
897
0.96
0.14
1.3
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
97
0.82
0.13
1.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
9
108
0.83
0.13
4.1
6.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
137
0.87
0.12
1.2
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
85
1.17
0.12
1.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
17
152
1.12
0.11
1.4
1.6
—
9.7
—
0
7
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
34
363
0.93
0.11
1.4
1.3
u/ml
2.7
4.8
0.52
15
122
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
103
993
1.04
0.11
1.3
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
69
660
1.04
0.10
1.2
1.2
—
0.8
—
0
5
(3000475) Leukocytes [#/volume] in Synovial fluid
110
1064
1.03
0.10
1.6
1.5
e6/l
25125.1
14815.9
0.90
81
773
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
32
340
0.94
0.10
1.1
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
48
456
1.05
0.09
1.1
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
46
1.08
0.09
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
106
1.13
0.09
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
114
1106
1.03
0.09
1.2
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
21
226
0.93
0.08
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
67
693
0.96
0.08
1.5
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
56
1.07
0.08
1.8
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
14
154
0.91
0.08
1.1
1.2
mmol/l
5.8
6.4
1.52
14
144
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
5
61
0.82
0.08
3.6
2.7
mg/l
6.8
6.3
—
5
50
(3002523) Influenza virus A Ag [Presence] in Specimen
19
205
0.92
0.08
1.0
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
65
0.77
0.08
3.4
2.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
6
70
0.85
0.07
1.0
1.9
ug/l
1.6
1.1
—
6
64
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
71
0.84
0.07
1.0
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
8
74
1.08
0.07
1.4
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
31
326
0.95
0.07
1.7
2.0
ug/l
1.6
1.8
0.30
24
267
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
179
1754
1.02
0.07
1.4
1.3
au/ml
29.5
50.0
—
5
72
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
86
1.04
0.07
1.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
16
147
1.09
0.07
1.1
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
92
0.87
0.06
1.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
8
94
0.85
0.06
9.9
11.2
nmol/l
697.0
751.2
—
8
87
(4306422)
32
335
0.95
0.06
1.2
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
203
0.93
0.06
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
92
940
0.98
0.06
1.5
1.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
89
1.12
0.06
1.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
111
0.90
0.06
1.2
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
265
1.05
0.06
1.1
1.1
u/ml
0.8
1.7
0.71
12
103
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
33
344
0.96
0.06
1.4
1.3
u/ml
9.5
5.7
0.34
14
164
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
12
109
1.10
0.06
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
70
680
1.03
0.05
2.0
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
51
525
0.97
0.05
3.7
3.8
umol/l
335.5
337.5
0.04
42
427
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
(4268621)
25
237
1.05
0.05
2.9
2.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
209
1.05
0.04
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
28
269
1.04
0.03
1.1
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
121
1.07
0.03
1.8
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
14
131
1.07
0.03
1.4
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
128
0.93
0.03
1.7
1.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
26
250
1.04
0.03
1.1
1.1
u/ml
0.9
4.9
—
5
74
(36660697) Celiac disease serology panel - Serum
208
2091
0.99
0.03
1.2
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
92
1.08
0.03
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
92
1.08
0.03
1.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
25
241
1.03
0.02
2.6
2.2
mmol/l
9.6
9.3
0.16
18
181
(3027456) Digoxin [Moles/volume] in Serum or Plasma
110
1089
1.01
0.01
3.1
3.1
nmol/l
0.8
0.8
0.23
83
838
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
30
293
1.02
0.00
1.3
1.8
—
2153.8
—
0
13
(4094501)
99
993
0.99
0.00
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
23
226
1.02
0.00
1.1
1.1
u/ml
4.9
4.2
—
10
96
(3034891) Synovial lining cells/100 cells in Synovial fluid
21
210
1.00
0.00
2.0
1.4
%
6.0
3.4
—
7
50
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
103
0.97
0.00
1.2
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
16
156
1.02
0.00
1.0
1.1
u/ml
0.5
2.0
—
6
64
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
18
180
1.00
0.00
1.5
1.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
224
1.02
0.00
1.1
1.1
u/ml
1.0
0.8
—
9
81
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
42
423
0.99
0.00
1.8
1.5
%
16.4
25.4
2.24
27
284
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
99
1.01
0.00
1.1
1.1
miu/ml
1216.7
1703.1
—
10
99
(3039162) Centromere protein B Ab [Units/volume] in Serum
32
317
1.01
0.00
1.1
1.2
—
50.2
—
0
20
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
50.6
—
0
5
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
80
1.00
0.00
1.8
1.5
ug/l
11.9
9.8
—
8
80
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
1.5
—
0
6
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
3.9
—
0
8
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.4
—
0
5
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
5
50
1.00
0.00
1.0
1.2
%
102.0
105.1
—
5
44
(3006567) Chloride [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
1211.7
—
0
6
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
6
0.00
0.00
0.0
2.3
—
685.5
—
0
6
(3036071) Salmonella sp Ab [Titer] in Serum
7
78
0.89
0.00
1.0
1.1
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
8
0.00
0.00
0.0
10.5
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012403) Metanephrines [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
28.2
—
0
9
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
64
0.94
0.00
1.0
1.2
%
106.5
89.4
—
6
55
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
57
0.87
0.00
1.4
1.1
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_BLADDER_EXALLC – Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)
GWS hits: 10
This endpoint is excluded (different definition than used in FinnGen).